Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
47.98
+0.52 (1.10%)
At close: Jul 3, 2025, 1:00 PM
47.75
-0.23 (-0.48%)
After-hours: Jul 3, 2025, 5:00 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $586.01M in the quarter ending March 31, 2025, with 110.67% growth. This brings the company's revenue in the last twelve months to $1.78B, up 85.99% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$1.78B
Revenue Growth
+85.99%
P/S Ratio
5.86
Revenue / Employee
$1,090,014
Employees
1,637
Market Cap
10.74B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 685.09B |
Costco Wholesale | 268.78B |
PepsiCo | 91.52B |
The Procter & Gamble Company | 83.93B |
Unilever | 62.91B |
Anheuser-Busch InBev | 58.85B |
The Coca-Cola Company | 46.89B |
Philip Morris International | 38.39B |
HIMS News
- 2 hours ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewsWire
- 3 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - PRNewsWire
- 4 days ago - Hims & Hers Can Still Thrive Without GLP-1s - Seeking Alpha
- 5 days ago - Hims & Hers Health: Buy The Novo Nordisk Drama Dip - Seeking Alpha
- 6 days ago - Hims & Hers: You Are Missing The Big Picture - Seeking Alpha
- 8 days ago - HIMZ: Buy For Short-Term Gains On Hims & Hers Health, But Be Wary Of The Risks - Seeking Alpha
- 9 days ago - Hims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing” Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura - Business Wire
- 10 days ago - HIMS SECURITIES: Lose Money on Hims & Hers Health, Inc. (NYSE:HIMS)? Contact BFA Law about the Pending Securities Fraud Investigation - GlobeNewsWire